Generali Asset Management SPA SGR purchased a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 5,788 shares of the company’s stock, valued at approximately $940,000.
Other institutional investors also recently modified their holdings of the company. Advisors Asset Management Inc. increased its position in Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after purchasing an additional 9,037 shares during the period. Natixis Advisors LLC boosted its stake in shares of Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after purchasing an additional 4,839 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after purchasing an additional 13,038 shares in the last quarter. Public Employees Retirement System of Ohio increased its holdings in shares of Clorox by 26.3% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company’s stock valued at $9,736,000 after purchasing an additional 12,428 shares in the last quarter. Finally, Fifth Third Wealth Advisors LLC acquired a new position in shares of Clorox during the fourth quarter valued at approximately $204,000. 78.53% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on CLX. Barclays lifted their price target on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Evercore ISI increased their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Wells Fargo & Company increased their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Finally, DA Davidson decreased their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $159.62.
Clorox Price Performance
NYSE CLX opened at $145.46 on Friday. The business has a 50 day simple moving average of $153.10 and a 200 day simple moving average of $159.87. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market cap of $17.92 billion, a price-to-earnings ratio of 39.74, a PEG ratio of 2.62 and a beta of 0.45. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the company posted $2.16 earnings per share. Analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.35%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 133.33%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Consumer Staples Stocks, Explained
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Bank Stocks – Best Bank Stocks to Invest In
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.